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Background: Non-ataxic symptoms of spinocerebellar ataxias (SCAs) vary widely and often overlap with various
types of SCAs. Duration and severity of the disease and genetic background may play a role in such phenotypic
diversity. We conducted the study in order to study clinical characteristics of common SCAs in Thailand and the
factors that may influence their phenotypes.
Methods: 131 (49.43%) out of 265 Thai ataxia families with cerebellar degeneration had positive tests for
SCA1, SCA2, Machado-Joseph disease (MJD) or SCA6. The study evaluated 83 available families including SCA1
(21 patients), SCA2 (15), MJD (39) and SCA6 (8). Comparisons of frequency of each non-ataxic sign among different
SCA subtypes were analysed. Multivariate logistic regression analyses were undertaken to analyze parameters in
association with disease severity and size of CAG repeat.
Results: Mean ages at onset were not different among patients with different SCAs (40.31 ± 11.33 years, mean ± SD).
Surprisingly, SCA6 patients often had age at onset and phenotypes indistinguishable from SCA1, SCA2 and MJD.
Frequencies of ophthalmoparesis, nystagmus, hyperreflexia and areflexia were significantly different among
the common SCAs, whilst frequency of slow saccade was not. In contrast to Caucasian patients, parkinsonism,
dystonia, dementia, and facial fasciculation were uncommon in Thai patients. Multivariate logistic regression
analysis demonstrated that ophthalmoparesis (p < 0.001) and sensory impairment (p = 0.025) were associated
with the severity of the disease.
Conclusions: We described clinical characteristics of the 4 most common SCAs in Thailand accounting for almost
90% of familial spinocerebellar ataxias. There were some different observations compared to Caucasian patients
including earlier age at onset of SCA6 and the paucity of extrapyramidal features, cognitive impairment and facial
fasciculation. Severity of the disease, size of the pathological CAG repeat allele, genetic background and somatic
heterogeneity of pathological alleles may influence clinical expressions of these common SCAs.
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Spinocerebellar ataxias (SCAs) are genetically heteroge-
neous neurodegenerative disorders associated with progres-
sive ataxia or less commonly episodic ataxia. Adult-onset
patients mainly inherit the condition by autosomal
dominant transmission. Phenotypes often accompany* Correspondence: teeratorn.pul@mahidol.ac.th
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article, unless otherwise stated.various non-ataxic signs including saccadic abnormal-
ities, ophthalmoplegia, extrapyramidal features, pyr-
amidal signs, polyneuropathy, amyotrophy, fasciculation,
dementia, and macular degeneration [1]. To date, the
Human Genome Nomenclature Committee has assigned
types of SCAs into SCA1 to SCA37 in association with 31
chromosomal loci and genes [1-5]. Machado-Joseph dis-
ease (MJD) or SCA3 is generally the most common form
of SCA worldwide [6-8]. Other common types of SCAs in
various ethnic groups include SCA1, SCA2, SCA6, SCA7d Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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these common SCAs are caused by expansions of polyglu-
tamine-encoding CAG repeat [1].
Phenotypes of different SCAs often overlap and are
indistinguishable resulting in a difficulty in making
clinical diagnosis. However, some clinical clues and epi-
demiological data of common SCAs in each population
may be helpful for setting up appropriate diagnostic gen-
etic tests [9,10]. For example, pyramidal signs are more
common in SCA1 and SCA3 while peripheral neuropathy
is more common in SCA2 [9,11,12]. Slow saccades may
be more prevalent in SCA2 [13,14]. Sizes of expanded
repeat allele, age at onset, age, and disease duration have
been described as factors that might influence clinical
expression of the common SCAs [15-17]. Although
neuropathology of the polyglutamine-associated SCAs
is generally widespread over the cerebellum, brain-
stem and cerebral hemisphere in the advance stage of
the diseases [18], observations of some non-ataxic signs
such as slow saccade in presymptomatic carriers or at
the early symptomatic stage suggest that other neu-
rons apart from cerebellar neurons may also be simi-
larly vulnerable to the pathological process caused by
the polyglutamine-associated SCAs [19,20]. Slow saccade
represents loss of excitatory burst neuronal function,
whose neurons initiate the pulse sequence of saccadic
eye movement [21]. Therefore degenerative process of
those neurons in brainstem should take place at a
very early stage of the disease in those patients [19,22].
Although slow saccades in SCA2 patients may be influ-
enced by the size of polyglutamine tract [17], this mechan-
ism cannot solely explain the presence or absence of slow
saccades in all SCA2 patients. Other genetic factors may
also play a role in selective neuronal susceptibility and
phenotypic expression of the polyglutamine-associated
SCAs [23].
MJD is the most common SCA in the Thai population
followed by SCA1, SCA2 and SCA6 [24]. Over the past
15 years, the study group has had experience of seeing
over a hundred Thai SCA families. Interestingly, we have
hardly observed some of the frequently described
non-ataxic signs comprising facial fasciculation, par-
kinsonism, dystonia, and dementia in those patients.
This finding implies that those signs might be less
common compared to previous reports of other eth-
nic groups. Furthermore, slow saccade was commonly
observed in all subtypes of the common SCAs. There-
fore the study was conducted in order to analyze the
clinical characteristics of the Thai patients with adult-
onset SCAs and identify factors that may influence
the clinical expression of SCAs. Since we have observed a
clinical concordance in the patients from the same family,
we thus recruited only the index patient from each family
into the study.Methods
Patients
We reviewed medical records of all patients with pro-
gressive cerebellar ataxia, who were tested for SCA1,
SCA2, MJD, SCA6, SCA7 and DRPLA at the Division
of Neurology, Department of Medicine, Ramathibodi
Hospital. After undertaking intensive investigations,
some of the patients were identified by other diagnoses
including cerebellar variant of multiple system atrophy,
neurogenic weakness, ataxia and retinitis pigmentosa
(NARP) and autoimmune cerebellar disorders. The re-
maining patients were from 265 families. 131 families
(49.43%) tested positive for SCA1 (38 families), SCA2
(22), MJD (61) and SCA6 (10). 75 of those families
(57.25%) had family history of ataxia. The study identified
SCA1, SCA2, MJD, or SCA6 mutations in almost 90% of
the patients in the familial group (75 of 86 families), while
only 31% of the sporadic cases (56 of 179 cases) were
identified as one of these common SCAs (Table 1). We
have not identified patients with SCA7 and DRPLA so far.
Details of the frequencies of SCAs were listed in Table 1.
The study subsequently enrolled 83 index patients
with SCA1, SCA2, MJD and SCA6 from the database,
who were available for clinical review and examination.
All accessible family members were also evaluated. How-
ever, statistical analyses only used data of the index
cases. The examination processes were undertaken at 4
participating hospitals during April 2010 to June 2013.
All of the participants were evaluated by T.P. and P.B., or
S.Po., or P.J. except for 2 families, who live in rural areas
of Phayao province in the northern part of Thailand. They
were examined by P.J. and S.T. Collected patient’s profiles
and clinical data included sex, the family’s hometown,
age at onset, disease duration, age at diagnosis, family
pedigrees, cerebellar signs, fundoscopic examination,
eye movement abnormalities, nystagmus, muscle tone,
tendon reflexes, Babinski’s sign, parkinsonism, dystonia,
chorea, dementia (Mini-mental state examination), fasci-
culation, sensory examination (vibration, joint position
and pin prick sensations) and scale for the assessment and
rating of ataxia (SARA). All patients provided both verbal
and written informed consent. The research protocol was
approved by the ethics committee or hospital ethical
review board of every participating university and hospital.
Genetic analysis
DNA samples were extracted from peripheral leukocyte
by phenol-chloroform method or using QIAGEN DNA
purification kit (QIAGEN, CA, USA). Fluorescently-
labelled PCR of the expanded repeat alleles of the
ATXN1 (ataxin 1), ATXN2, ATXN3, CACNA1A (alpha
1A subunit, P/Q type voltage-dependent calcium chan-
nel: SCA6), ATXN7 and ATN1 (atrophin 1: DRPLA)
genes were performed by using primer sets as previously
Table 1 Frequencies of the common spinocerebellar ataxias in Thai patients
Familial group (%) N = 86 Sporadic group (%) N = 179 Total (%) n = 265
SCA1 19 (22.10) 19 (10.61) 38 (14.34)
SCA2 10 (11.63) 12 (6.70) 22 (8.30)
MJD 40 (46.51) 21 (11.73) 61 (23.02)
SCA6 6 (6.98) 4 (2.23) 10 (3.77)
Total 75 (87.21) 56 (31.28) 131 (49.43)
Patients without mutation 11 (12.79) 123 (68.72) 134 (50.57)
Abbreviations as follows: SCA spinocerebellar ataxia, MJD Machado-Joseph disease.
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then determined by running the PCR products on
Beckman CEQ8800 DNA Analysis System (Beckman
Coulter, CA, USA). Sizes of CAG repeat of both normal
and pathological alleles of each chromosome were cal-
culated by comparing results with the size of a normal
control sample, of which the sizes were prior defined by
direct sequencing. In order to avoid a false negative result
caused by a very large expanded allele failing to be ampli-
fied by using regular PCR [29]. all samples whose results
showed patterns of homozygous wild-type alleles of
ATXN1, ATXN2 and ATXN3, were subsequently re-
analyzed by performing long-range PCR using LA Taq
polymerase (TaKaRa, Chiba, Japan).
Statistical analysis
Results were expressed as means ± standard deviations.
One-way analysis of variance (ANOVA) was used to com-
pare means of each continuous variable among different
SCAs. Categorical variables were compared by using chi
squared test. Test results considered significant differences
at the level of p-value < 0.05. Comparisons of clinical
characteristics between groups of patients with SARA
score <15 and ≥15 were determined by logistic regression
analysis. The results were expressed as odd ratio (OR),
95% confidence intervals (CI) and p-values. After a num-
ber of univariate predictive factors had been determined,
forward stepwise selection was carried out to determine
the appropriate multivariate model. Factors selected for
the multivariate model were those found significant in the
univariate model. Results were considered statistically
significant for p <0.10 of univariate and p <0.05 of multi-
variate analysis. Whether size of the pathological SCA3
repeat allele influences the clinical outcomes was tested
by logistic regression analysis and then adjusted with other
factors including age at onset, age, sex and duration of the
disease. All analyses were performed using STATA version
12 (Stata Corp., College Station, TX, USA).
Results
Patient characteristics
MJD is the most common type of adult-onset spinocere-
bellar ataxias in the study followed by SCA1, SCA2 andSCA6, respectively (Table 1). Eighty-three index pa-
tients were enrolled on the study including 39 MJD
patients, 21 SCA1, 15 SCA2 and 8 SCA6 patients.
Analyses of their family pedigrees identified at least 297
affected relatives. Overall patient characteristics are sum-
marized in Table 2.
Thailand is geographically divided into six regions com-
prising central, north, northeast, east, west and south. Most
of the patients in the study lived in central, north, west and
northeast of Thailand. Only four patients were referred
from eastern (2) and southern (2) regions (Figure 1). In
central, western and northern regions, we identified pa-
tients with SCA1, SCA2, MJD and SCA6. However, almost
all families living in the northeastern region were SCA1
and MJD. Only one family was SCA2 and no SCA6 family
was identified in the region.
General factors including gender, age at onset, duration
of disease, positive family history and SARA scale were
not different among the different types of SCAs (Table 2).
Average age at onset was around late thirties to early for-
ties in all groups. SCA6 did not correlate with later age at
onset compared to the other SCAs (43.5±6.76, mean±SD).
Furthermore, none of the studied SCA6 patients had age
at onset after 60 years. Durations of the disease and SARA
scales were similar in all groups.
Clinical features
Gait ataxia or unsteadiness was the presenting symptom
in all cases. Arm incoordination and cerebellar dysarthria
generally followed within a few to several years. Limb
ataxia was sometimes asymmetrical; however difference of
severity was frequently not in a large degree. Truncal
ataxia was uncommon until the advance stage of the
disease. In the early stage, neurological signs including
dysmetric saccades, nystagmus and pyramidal signs par-
ticularly increased tendon reflexes and spastic tone in
both legs could often be observed. We had the opportun-
ity to examine several asymptomatic carriers of MJD at
the age between 22 to 30 years. Some of them had brisk
tendon reflexes and mild spasticity in both legs, although
they did not have gait unsteadiness.
Frequencies of nystagmus, upward gaze paresis, hyper-
reflexia and areflexia were significantly different among
Table 2 Comparison of clinical profile and features of unrelated Thai patients with SCA1, SCA2, MJD and SCA6
SCA1 SCA2 MJD SCA6 p-value*
Total numbers 21 15 39 8
Sex (M/F) 11/10 8/7 14/25 4/4 0.500
Age at onset (years)
Mean age at onset 38.43 41.47 39.97 43.5 0.715
SD 10.14 13.01 12.17 6.76
Range 15 – 55 19 - 60 16 - 64 34 - 58
Duration (years)
Mean duration 5.43 3.93 6.62 6 0.328
SD 5.13 2.99 5.01 5.90
Range 1 - 20 1 - 10 0.25 - 22 1 - 18
Positive family history (%) 16 (76.2) 13 (86.7) 32 (82.1) 7 (87.5) 0.900
CAG repeat size (repeats)
Mean 50.14 37.40 69.97 21.88
SD 6.27 4.47 4.04 0.83
Range 41 – 65 32 - 52 62 - 78 21 - 23
Clinical features (%)
Slow saccade 12 (57.1) 7 (46.7) 21 (53.9) 2 (25) 0.454
Horizontal nystagmus 5 (23.8) 4 (26.7) 34 (87.2) 6 (75) 0.0000002**
Vertical nystagmus 0 (0) 1 (6.7) 6 (15.4) 3 (37.5) 0.026**
Opthalmoparesis 6 (28.6) 3 (20.0) 26 (66.7) 2 (25) 0.002**
Pale optic disc 1 (4.8) 0 (0) 2 (5.1) 1 (12.5) 0.610
Hyperreflexia 19 (90.5) 5 (33.3) 26 (66.7) 7 (87.5) 0.002**
Babinski’s sign 11 (52.4) 5 (33.3) 17 (43.6) 5 (62.5) 0.510
Areflexia 0 (0) 5 (35.7) 9 (23.1) 0 (0) 0.011**
Sensory impairment 4 (19.0) 3 (20.0) 9 (23.1) 0 (0) 0.630
Parkinsonism 0 (0) 0 (0) 0 (0) 0 (0) 1.000
Dystonia 1 (4.8) 0 (0) 1 (2.6) 0 (0) 0.475
Chorea 0 (0) 0 (0) 1 (2.6) 0 (0) 1.000
Dementia 0 (0) 1 (6.7) 0 (0) 1 (12.5) 0.074
Facial fasciculation 2 (9.5) 0 (0) 5 (12.8) 0 (0) 0.579
SARA
Mean scale 16.97 13.18 16.76 15.71 0.767
SD 7.45 3.66 7.27 7.24
Range 4 - 30 9 - 20 8 - 35 3.5 - 27
*Continuous variables were analyzed by using ANOVA. Comparisons of frequencies of clinical profiles and features were analyzed by using Fisher’s exact test.
**P < 0.05 is considered as significant difference.
Abbreviations as follows: SCA spinocerebellar ataxia, MJD Machado-Joseph disease, SD standard deviation, SARA scale for the assessment and rating of ataxia.
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commonly gaze-evoked type. Horizontal nystagmus was
more common than vertical nystagmus. It was relatively
more common in MJD and SCA6 than the other types.
Ophthalmoparesis was invariably upward direction and
it was significantly more frequent in MJD than other
SCAs. Almost all patients who exhibited upward gaze
paresis, were nuclear type. Supranuclear gaze paresis
was rare in the patients studied and it was observed inonly a few patients in the early stage of the disease. Severe
ophthalmoparesis in all directions was observed in only a
few patients with advance stage of SCA1 and MJD.
Increased tone and tendon reflexes were generally more
prominent in the lower extremities. It was common in all
studied subtypes of SCAs except SCA2. It was noted that
almost all patients with SCA1 (90%) developed pyramidal
signs. One of the only two SCA1 patients, who did not
have pyramidal signs, had severe generalized dystonia.
Figure 1 Map of Thailand illustrates the distribution of the
frequencies of the common SCAs.
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was less often accompanied with absent knee reflexes or
generalized areflexia. Absent ankle reflexes were also ob-
served in the presence of brisk knee reflexes and Babinski’s
sign. Areflexia was not apparent in both SCA1 and SCA6
in the study. Sensory symptoms were usually subtle and
the impairment of vibration or pin prick sensations was
observed in about one-fifth of the SCA1, SCA2 and MJD
patients. Only two patients studied (SCA2 and MJD) had
severe axonal sensorimotor polyneuropathy. They devel-
oped generalised areflexia, marked distal wasting, mild
distal weakness and sensory loss in gloves and stockings
pattern since the early stage of the disease.
Abnormal saccadic eye movements were demonstrated
in all subtypes of the studied SCAs. Slow saccades were
found in about half of the patients. With the exception
of SCA6, it was observed in only a quarter of the patients.However, frequencies of slow saccades were not different
among different SCAs (p = 0.454). Dysmetric saccades
(both hypermetric and hypometric saccades) and impair-
ment of vestibulo-ocular-reflex suppression were also
identified in a large proportion of the examined patients
of all SCA subtypes. However, we did not systematically
record this data from the beginning of the study.
Facial fasciculation, dystonia, chorea and cognitive
impairment were uncommon in the patients studied.
Facial fasciculation was only observed in a few patients
with SCA1 and MJD. Both periorbital and orolingual
distribution was equally observed, and it was often
asymmetry. Fasciculation was much rarer in the extrem-
ities. Dystonia was actually observed in only two families
with SCA1 and MJD. The SCA1 patient had severe
generalized dystonia and the MJD patient had unilateral
foot dystonia prominently only while walking. None of
the patients studied had signs of parkinsonism. General-
ized chorea was present in two unrelated MJD patients
including one index case and one affected family members
(not included in the analysis). Both patients were in the
advanced stage. One of the patients had been wheel-chair
bound and the other had been confined to bed for over
3 years.
Disease severity and non-ataxic symptoms
Comparisons of demographic data and clinical features
between patients with SARA ≥ 15 and <15 are shown in
Table 3. Since age at onset and age are correlated, they
theoretically may cause multicollinearity. Therefore, we
applied two separate models of logistic regression analyzes
by using age at onset or age as parameter. After perform-
ing multivariate analysis, ophthalmoparesis and sensory
impairment were shown to be independently associated
with disease severity by both models (Table 4). Age was
also a factor associated with severity of the disease when
age at onset was excluded from the analysis (model 2 in
Table 4).
Sizes of expanded SCA3 alleles and non-ataxic symptoms
Univariate logistic regression analysis revealed that size of
the pathological SCA3 repeat allele >70 was associated
with the presence of increased tendon reflexes (OR = 5.33,
95% CI = 1.17-25.21, p = 0.03). However, the association
was excluded after adjustment with age, age at onset, sex
and disease duration (OR = 2.38, 95% CI = 0.56-10.03,
p = 0.24).
Discussion
Overall, MJD was the most common SCA in Thailand
similar to other East Asian countries except Korea, in
which SCA2 appeared to be the most common SCA [30].
DRPLA is rare in Chinese and Thais, while it is relatively
common in Japan, Singapore and Korea [30-32]. Apart
Table 3 Comparison of baseline factors between SARA ≥15
and SARA <15 groups
Factors SARA ≥15
N = 49 (%)
SARA <15
N = 34 (%)
p-value
Sex
Female 23 (46.9) 14 (41.2) 0.603
Age onset (years); mean (SD) 42.1 (11.1) 37.5 (11.3) 0.071
Age when exam (years); mean (SD) 50.5 (11.7) 39.5 (11.3) <0.001
Duration (years); mean (SD) 8.9 (5.1) 3.4 (2.2) <0.0001
SCA Type
SCA 1 13 (26.5) 8 (23.5) 0.325
SCA 2 6 (12.2) 9 (26.5)
SCA 3 26 (53.1) 13 (38.2)
SCA 6 4 (8.2) 4 (11.8)
Family history 44 (89.8) 24 (70.6) 0.025
Slow saccades 29 (59.2) 14 (41.2) 0.106
Horizontal nystagmus 32 (65.3) 17 (50) 0.163
Vertical nystagmus 8 (16.3) 2 (5.9) 0.187
Upward gaze paresis 31 (63.3) 6 (17.6) <0.001
Hyperreflexia 37 (75.5) 20 (58.8) 0.107
Areflexia 10 (20.4) 4 (11.8) 0.301
Babinski’s sign 26 (53.1) 12 (35.3) 0.110
Sensory impairment 14 (28.6) 2 (5.9) 0.010
Optic atrophy 4 (8.2) 0 (0) 0.141
Table 4 Univariate and multivariate logistic regression analyse
(SARA≥ 15); (Tables show only significant parameters)
Univariate analysis
Variable All 4 common SCA
Odd ratio (95% CI)
Age at onset (years) 1.04 (0.99-1.08)
Age when assessment (years) 1.08 (1.04-1.13)
Positive family history 3.67 (1.12-11.97)
Ophthalmoparesis 8.07 (2.80-23.10)
Sensory impairment 6.40 (1.35-30.37)
Babinski’s sign not significant
Multivariate logistic regression analysis: model 1 Consider age at onset a
Variable All 4 common SCA
Odd ratio (95% CI)
Ophthalmoparesis 8.19 (2.74-24.44)
Sensory impairment 6.64 (1.27-34.71)
Model 2 Consider age as parameter
Variable All 4 common SCA
Odd ratio (95% CI)
Age when assessed 1.07 (1.02-1.13)
Ophthalmoparesis 6.18 (1.90-20.03)
Sensory impairment 9.28 (1.43-60.07)
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East Asian populations, in contrast to Japanese, in which
SCA6 and SCA31 are the second common SCA, and
frequencies of SCA1 and SCA2 are less common [31,33].
We described clinical characteristics of the four most
common SCAs in Thailand including MJD, SCA1, SCA2
and SCA6. This data showed that the main clinical fea-
tures of Thai patients were similar to the previous reports
of other ethnic groups to some extent [9,13,15,16,34-37].
However, there were also noticeable differences in some
aspects between Thai patients and patients of other ethnic
groups including (1) frequent observation of slow saccades
in all of the studied types of SCA; (2) the relatively less
frequent neuropathy and more frequent pyramidal signs
in SCA2; (3) the relatively earlier onset of SCA6 in Thais;
and (4) the scarcity of extrapyramidal features and cogni-
tive impairment. Nevertheless, phenotypes of the common
SCAs are generally very heterogeneous and frequencies of
associated non-ataxic symptoms among different popula-
tions are widely diverse. Therefore, the findings are not
surprising. However, these data suggest that the clinical
clues for differential diagnosis of the common types of
SCAs such as age at onset, slow saccade and areflexia may
be less useful in the Thai patients.
Slow saccade has been well-known as one of the major
non-ataxic features of SCA2 [9,17,22,38]. Reduced sac-
cadic velocity can be apparent in presymptomatic carriers
of SCA2 implying that oculomotor pontine nuclei likely tos of parameters associated with more severe ataxia group
s MJD, SCA1 and SCA2
p-value Odd ratio (95% CI) p-value
0.075 1.04 (1.01-1.09) 0.036
<0.001 1.08 (1.04-1.14) <0.001
0.031 5.13 (1.43-18.37) 0.012
<0.001 7.25 (2.45-21.41) <0.001
0.019 6.32 (1.32-30.31) 0.021
2.67 (1.01-7.07) 0.049
s parameter
s MJD, SCA1 and SCA2
p-value Odd ratio (95% CI) p-value
<0.001 7.56 (2.44-23.42) <0.001
0.025 6.82 (1.29-36.01) 0.024
s MJD, SCA1 and SCA2
p-value Odd ratio (95% CI) cx-value
0.004 1.08 (1.03-1.14) 0.003
0.002 5.62 (1.64-19.26) 0.006
0.019 9.41 (1.40-63.34) 0.021
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cerebellar neurons [19]. Previous evidence also suggested
that the occurrence of slow saccade might be associated
with size of the pathological repeat alleles and its severity
was subsequently progressive over time [17,22]. Slow sac-
cade was less often reported in association with SCA1,
MJD and SCA6 [39], though our data showed similar
frequencies of slow saccade among these SCAs. So the
mechanism underlying the susceptibility of specific neu-
rons other than cerebellar neurons to the neurodegenera-
tive process caused by these polyglutamine diseases is
likely to be complex and may involve other genetic factors
apart from specific genes and the size of the pathological
repeat alleles.
Not only is the frequency of peripheral neuropathy
often more common in SCA2 than the other common
subtypes, the SCA2 patients also develop polyneuropathy
at an early stage of the disease [40]. A large European
study revealed that the occurrence of peripheral neur-
opathy in SCA2 was not associated with disease duration.
In contrast to MJD and SCA6, polyneuropathy might
relate to disease duration, which tended to develop in the
later stage [15]. These data implied that a susceptibility to
neuropathy was greater associated with the trinucleotide
repeat expansion in ATXN2 gene than the others. Al-
though polyneuropathy was less frequent in the Thai
SCA2 patients compared to other ethnic groups, and
frequencies of polyneuropathy were not much different
between SCA2 and MJD. The study also observed that
evidence of peripheral neuropathy appeared to be occur-
rence in the early stage of SCA2 in contrast to a later stage
in association with MJD similar to previous reports.
SCA6 has been generally known to be progressive
ataxia with later onset compared to SCA1, SCA2 and
MJD, in which age at onset may be after 60 years old
[41-43]. Some evidence suggested that age at onset of
SCA6 might be inversely related to size of CAG repeats,
with the larger size of the CAG repeats more likely to be
associated with the early age at onset [42]. All of the
patients studied had sizes of CAG repeats of 23 or lower,
thus it is unlikely that this finding related to the size of
CAG repeat. However, the study group is small. So we
then further reviewed medical records of all of the ten
SCA6 families in our clinics. Of the 18 patients from
unrelated 10 SCA6 families, mean age of onset was
42.6 years, range 34–61 years. Only one patient had age
at onset over 60 years old. Regarding the data of age at
onset of the Thai SCA6 patients together with a high
frequency of prominent pyramidal signs, nystagmus and
saccadic abnormalities, it is difficult to clinically distin-
guish SCA6 from MJD, SCA1 and SCA2.
In the study, the Thai SCA patients rarely exhibit par-
kinsonism, dystonia, dementia and facial fasciculation.
Parkinsonism has been reported to be relatively commonin SCA2 and SCA3 [44-47]. None of the studied patients
exhibited parkinsonian features. In the study, we evaluated
cognitive functions by using history taking and bedside
examination. Almost all of the patients did not clinically
have cognitive impairment and dementia. It was quite un-
common even in the late stage of the disease. Regarding
dystonia, it has not been a commonly described non-
ataxic feature of SCAs [48], dystonia is also extremely rare
in the Thai patients.
The multiple regression analyses suggested that the
development of ophthalmoparesis and polyneuropathy
may be associated with severity of the disease and age of
the patients rather than the subtypes of SCAs. However,
the study had some limitations. The sample size is rela-
tively small since we recruited only index cases of each
family. So the study performed two logistic regression
analyses including: (1) all patients together, and (2) all
patients except SCA6. Since underlying pathological
process of SCA6 is a small CAG expansion, which is
different from other SCAs studied. Secondly, a large
proportion of our patients were of low socioeconomic
and low-educated status. They might give inaccurate
data of some important information such as age at onset
and disease duration.
Conclusions
In summary, MJD, SCA1, SCA2 and SCA6 are common
in Thai adult-onset cerebellar degeneration, in contrast
to SCA7 and DRPLA which are rare. The Thai patients
with MJD, SCA1, SCA2 and SCA6 often exhibited a
similar non-ataxic phenotype including pyramidal features
prominently in lower limbs, saccadic abnormalities and
less often peripheral neuropathy. The study shows that
slow saccades and age onset are of no value for differential
diagnosis of the common SCA subtypes in Thailand.
Thus, it is essential to set up an effective referral system
for reachable genetic diagnosis of a panel of at least the
four common SCAs in Thailand.
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